Molecular therapeutics in breast cancer
21 – 24 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2014
-
Mark
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium
(
- Contribution to journal › Article
-
Mark
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
A novel model of dormancy for bone metastatic breast cancer cells
(
- Contribution to journal › Article
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »